comparison of levetiracetam with phenobarbitone in neonatal seizure
Phase 3
- Conditions
- Health Condition 1: null- all neonates with convulsion of any cause
- Registration Number
- CTRI/2013/01/003310
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
all newborns <28 days with convulsions of any cause.
Exclusion Criteria
babies on mechanical ventilation and with refractory shock
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method control of clinical seizureTimepoint: 24 hrs
- Secondary Outcome Measures
Name Time Method side effects of levetiracetam <br/ ><br>nuerological outcome at age 3,6,12 monthsTimepoint: 12 months